Search Results - "ten Berge, I.J.M."

Risk Factors for Delayed Graft Function After Hand-Assisted Laparoscopic Donor Nephrectomy by Minnee, R.C, Bemelman, W.A, Donselaar-van der Pant, K.A.M.I, Booij, J, ter Meulen, S, ten Berge, I.J.M, Legemate, D.A, Bemelman, F.J, Idu, M.M

“…Abstract Background Delayed graft function (DGF) has a negative effect on the results of living-donor kidney transplantation. Objective To investigate…”
Get full text

Primary immunodeficiencies in the Netherlands: National patient data demonstrate the increased risk of malignancy by Jonkman-Berk, B.M, van den Berg, J.M, ten Berge, I.J.M, Bredius, R.G.M, Driessen, G.J, Dalm, V.A.S.H, van Dissel, J.T, van Deuren, M, Ellerbroek, P.M, van der Flier, M, van Hagen, P.M, van Montfrans, J.M, Rutgers, A, Schölvinck, E.H, de Vries, E, van Beem, R.T, Kuijpers, T.W

“…Abstract Purpose To analyze the data of the national registry of all Dutch primary immune deficiency (PID) patients, according to the European Society for…”
Get full text

17D yellow fever vaccine elicits comparable long-term immune responses in healthy individuals and immune-compromised patients by Wieten, R.W, Goorhuis, A, Jonker, E.F.F, de Bree, G.J, de Visser, A.W, van Genderen, P.J.J, Remmerswaal, E.B.M, ten Berge, I.J.M, Visser, L.G, Grobusch, M.P, van Leeuwen, E.M.M

“…Summary Background The 17D live attenuated yellow fever (YF) vaccine is contra-indicated in immune-compromised individuals and may elicit a suboptimal…”
Get full text

The PROCARE consortium: Toward an improved allocation strategy for kidney allografts by Otten, H.G, Joosten, I, Allebes, W.A, van der Meer, A, Hilbrands, L.B, Baas, M, Spierings, E, Hack, C.E, van Reekum, F, van Zuilen, A.D, Verhaar, M.C, Bots, M.L, Seelen, M.A.J, Sanders, J.S.F, Hepkema, B.G, Lambeck, A.J, Bungener, L.B, Roozendaal, C, Tilanus, M.G.J, Vanderlocht, J, Voorter, C.E, Wieten, L, van Duijnhoven, E, Gelens, M, Christiaans, M, van Ittersum, F, Nurmohamed, A, Lardy, N.M, Swelsen, W.T, van Donselaar-van der Pant, K.A.M.I, van der Weerd, N.C, ten Berge, I.J.M, Bemelman, F.J, Hoitsma, A.J, de Fijter, J.W, Betjes, M.G.H, Roelen, D.L, Claas, F.H.J

“…Abstract Kidney transplantation is the best treatment option for patients with end-stage renal failure. At present, approximately 800 Dutch patients are…”
Get full text

ABO-incompatible kidney transplantation outcomes: A single centre experience by van Sandwijk, M.S, Bemelman, F.J, Donselaar-van der Pant, K.A.M.I, van der Weerd, N.C, de Jong, T, ten Berge, I.J.M

Get full text

CD27bright CD45RAbright CD8 T cells expressing Eomes, T-Bet and Hobit: Naïve T cells losing innocence? by Remmerswaal, E.B.M, van Aalderen, M.C, van der Bom-Baylon, N, van Donselaar-van der Pant, K.A.M.I, Bemelman, F.J, Kragten, N.A.M, Vieira Braga, F.A, ten Brinke, A, van Lier, R.A.W, ten Berge, I.J.M

Get full text

First Clinical Experience With Polysol Solution: Pilot Study in Living Kidney Transplantation by Schreinemachers, M.-C.J.M, Bemelman, F.J, Idu, M.M, van Donselaar-van der Pant, K.A.M.I, van de Berg, P.J.E.J, Reitsma, J.B, Legemate, D.A, Florquin, S, ten Berge, I.J.M, Doorschodt, B.M, van Gulik, T.M

“…Abstract In this study, we assessed the safety of the new organ preservation solution polysol solution in the clinical setting of living kidney…”
Get full text

Donor feces infusion for eradication of Extended Spectrum beta-Lactamase producing Escherichia coli in a patient with end stage renal disease by Singh, R., van Nood, E., Nieuwdorp, M., van Dam, B., ten Berge, I.J.M., Geerlings, S.E., Bemelman, F.J.

Get full text

Differential effects of donor‐specific HLA antibodies in living versus deceased donor transplant by Kamburova, E. G., Wisse, B. W., Joosten, I., Allebes, W. A., Meer, A., Hilbrands, L. B., Baas, M. C., Spierings, E., Hack, C. E., Reekum, F. E., Zuilen, A. D., Verhaar, M. C., Bots, M. L., Drop, A. C. A. D., Plaisier, L., Seelen, M. A. J., Sanders, J. S .F., Hepkema, B. G., Lambeck, A. J. A., Bungener, L. B., Roozendaal, C., Tilanus, M. G. J., Voorter, C. E., Wieten, L., Duijnhoven, E. M., Gelens, M., Christiaans, M. H. L., Ittersum, F. J., Nurmohamed, S. A., Lardy, N. M., Swelsen, W., Pant, K. A., Weerd, N. C., Berge, I. J. M., Bemelman, F. J., Hoitsma, A., Boog, P. J. M., Fijter, J. W., Betjes, M. G. H., Heidt, S., Roelen, D. L., Claas, F. H., Otten, H. G.

“…The presence of donor‐specific anti‐HLA antibodies (DSAs) is associated with increased risk of graft failure after kidney transplant. We hypothesized that DSAs…”
Get full text

Meningococcal Sepsis Complicating Eculizumab Treatment Despite Prior Vaccination by Struijk, G. H., Bouts, A. H. M., Rijkers, G. T., Kuin, E. A. C., ten Berge, I. J. M., Bemelman, F. J.

Get full text

Cytomegalovirus infection in solid organ transplant recipients by Lumbreras, C., Manuel, O., Len, O., ten Berge, I.J.M., Sgarabotto, D., Hirsch, H.H

“…Cytomegalovirus (CMV) is the most frequent infectious complication following solid organ transplantation (SOT). The virus, is responsible for both direct…”
Get full text

The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection by Singh, R., Nieuwdorp, M., ten Berge, I.J.M., Bemelman, F.J., Geerlings, S.E.

“…This review gives an outline of the indications for faecal microbiota transplantation (FMT) for diseases other than Clostridium difficile (C. difficile)…”
Get full text

Virus‐Specific CD8+ T Cells Cross‐Reactive to Donor‐Alloantigen Are Transiently Present in the Circulation of Kidney Transplant Recipients Infected With CMV and/or EBV by Heutinck, K. M., Yong, S. L., Tonneijck, L., Heuvel, H., Weerd, N. C., Pant, K. A. M. I., Bemelman, F. J., Claas, F. H. J., Berge, I. J. M.

“…T cells play a dual role in transplantation: They mediate transplant rejection and are crucial for virus control. Memory T cells generated in response to…”
Get full text

Deep sequencing of antiviral T-cell responses to HCMV and EBV in humans reveals a stable repertoire that is maintained for many years by Klarenbeek, P L, Remmerswaal, E B M, ten Berge, I J M, Doorenspleet, M E, van Schaik, B D C, Esveldt, R E E, Koch, S D, ten Brinke, A, van Kampen, A H C, Bemelman, F J, Tak, P P, Baas, F, de Vries, N, van Lier, R A W

“…CD8(+) T-cell responses against latent viruses can cover considerable portions of the CD8(+) T-cell compartment for many decades, yet their initiation and…”
Get full text

Early Conversion to Prednisolone/Everolimus as an Alternative Weaning Regimen Associates With Beneficial Renal Transplant Histology and Function: The Randomized‐Controlled MECANO Trial by Bemelman, F. J., Fijter, J. W., Kers, J., Meyer, C., Peters‐Sengers, H., Maar, E. F., Pant, K. A. M. I., Vries, A. P. J., Sanders, J.‐S., Zwinderman, A., Idu, M. M., Berger, S., Reinders, M. E. J., Krikke, C., Bajema, I. M., Dijk, M. C., Berge, I. J. M., Ringers, J., Lardy, J., Roelen, D., Moes, D.‐J., Florquin, S., Homan van der Heide, J. J.

“…In renal transplantation, use of calcineurin inhibitors (CNIs) is associated with nephrotoxicity and immunosuppression with malignancies and infections. This…”
Get full text

Incidence, risk factors, and the impact of allograft pyelonephritis on renal allograft function by Singh, R., Geerlings, S.E., Peters-Sengers, H., Idu, M.M., Hodiamont, C.J., ten Berge, I.J.M., Bemelman, F.J.

“…Background The impact of allograft pyelonephritis (AGPN) on renal allograft function is controversial. In this study, we evaluated the incidence, risk factors,…”
Get full text

Immunization after renal transplantation: current clinical practice by Struijk, G.H., Lammers, A.J.J., Brinkman, R.J., Lombarts, M.J.M.H., van Vugt, M., van der Pant, K.A.M.I., ten Berge, I.J.M., Bemelman, F.J.

“…Background The use of potent immunosuppressive drugs and increased travel by renal transplant recipients (RTR) has augmented the risk for infectious…”
Get full text

Mumps: Not an Innocent Bystander in Solid Organ Transplantation by Baas, M. C., Van Donselaar, K. A. M. I., Florquin, S., Van Binnendijk, R. S., Ten Berge, I. J. M., Bemelman, F. J.

“…Recently two major outbreaks of mumps have occurred: in the UK more than 56,000 cases were notified between 2004 and 2005, and in the United States, 6,584…”
Get full text

Renal expression of CD44 correlates with acute renal allograft rejection by Rouschop, K.M.A., Roelofs, J.J.T.H., Sylva, M., Rowshani, A.T., ten Berge, I.J.M., Weening, J.J., Florquin, S.

“…As CD44 is involved in the activation, proliferation, adhesion, and extravasation of lymphocytes, we hypothesized that CD44 could be involved in the…”
Get full text

pyrimidin analogue cyclopentenyl cytosine induces alloantigen-specific non-responsiveness of human T lymphocytes by Nikolaeva, N, Bemelman, F.J, Yong, S.-L, Verschuur, A, van Lier, R.A.W, ten Berge, I.J.M

“…Cyclopentenyl cytosine (CPEC) has been shown to induce apoptosis in human T lymphoblastic cell lines and T cells from leukaemia patients. In this study we have…”
Get full text